These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 15369772
1. Down-regulation of procaspase-8 expression by focal adhesion kinase protects HL-60 cells from TRAIL-induced apoptosis. Tamagiku Y, Sonoda Y, Kunisawa M, Ichikawa D, Murakami Y, Aizu-Yokota E, Kasahara T. Biochem Biophys Res Commun; 2004 Oct 15; 323(2):445-52. PubMed ID: 15369772 [Abstract] [Full Text] [Related]
2. Antiapoptotic action of focal adhesion kinase (FAK) against ionizing radiation. Kasahara T, Koguchi E, Funakoshi M, Aizu-Yokota E, Sonoda Y. Antioxid Redox Signal; 2002 Jun 15; 4(3):491-9. PubMed ID: 12215217 [Abstract] [Full Text] [Related]
3. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related]
4. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1. Liu XW, Taube ME, Jung KK, Dong Z, Lee YJ, Roshy S, Sloane BF, Fridman R, Kim HR. Cancer Res; 2005 Feb 01; 65(3):898-906. PubMed ID: 15705888 [Abstract] [Full Text] [Related]
5. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K, Douglas L, Delaney AB, Houghton JA. Cancer Res; 2004 Nov 01; 64(21):8036-44. PubMed ID: 15520213 [Abstract] [Full Text] [Related]
6. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Walczak H, Bouchon A, Stahl H, Krammer PH. Cancer Res; 2000 Jun 01; 60(11):3051-7. PubMed ID: 10850456 [Abstract] [Full Text] [Related]
7. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Ng CP, Zisman A, Bonavida B. Prostate; 2002 Dec 01; 53(4):286-99. PubMed ID: 12430140 [Abstract] [Full Text] [Related]
8. Mutated focal adhesion kinase induces apoptosis in a human glioma cell line, T98G. Sakurai S, Sonoda Y, Koguchi E, Shinoura N, Hamada H, Kasahara T. Biochem Biophys Res Commun; 2002 Apr 26; 293(1):174-81. PubMed ID: 12054581 [Abstract] [Full Text] [Related]
9. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P. Cancer Res; 2001 Oct 01; 61(19):7339-48. PubMed ID: 11585775 [Abstract] [Full Text] [Related]
10. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Ozören N, El-Deiry WS. Neoplasia; 2002 Oct 01; 4(6):551-7. PubMed ID: 12407450 [Abstract] [Full Text] [Related]
11. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. Sonoda Y, Matsumoto Y, Funakoshi M, Yamamoto D, Hanks SK, Kasahara T. J Biol Chem; 2000 May 26; 275(21):16309-15. PubMed ID: 10821872 [Abstract] [Full Text] [Related]
12. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Shi RX, Ong CN, Shen HM. Cancer Res; 2005 Sep 01; 65(17):7815-23. PubMed ID: 16140950 [Abstract] [Full Text] [Related]
13. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P. Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094 [Abstract] [Full Text] [Related]
14. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential. Hotta T, Suzuki H, Nagai S, Yamamoto K, Imakiire A, Takada E, Itoh M, Mizuguchi J. J Orthop Res; 2003 Sep 15; 21(5):949-57. PubMed ID: 12919886 [Abstract] [Full Text] [Related]
15. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells. Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A. Gynecol Oncol; 2004 Jun 15; 93(3):594-604. PubMed ID: 15196850 [Abstract] [Full Text] [Related]
16. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Kandasamy K, Srinivasula SM, Alnemri ES, Thompson CB, Korsmeyer SJ, Bryant JL, Srivastava RK. Cancer Res; 2003 Apr 01; 63(7):1712-21. PubMed ID: 12670926 [Abstract] [Full Text] [Related]
17. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Izeradjene K, Douglas L, Tillman DM, Delaney AB, Houghton JA. Cancer Res; 2005 Aug 15; 65(16):7436-45. PubMed ID: 16103097 [Abstract] [Full Text] [Related]
18. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells. Hao JH, Yu M, Liu FT, Newland AC, Jia L. Cancer Res; 2004 May 15; 64(10):3607-16. PubMed ID: 15150119 [Abstract] [Full Text] [Related]
19. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Perkins CL, Fang G, Kim CN, Bhalla KN. Cancer Res; 2000 Mar 15; 60(6):1645-53. PubMed ID: 10749135 [Abstract] [Full Text] [Related]
20. Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells. Lashinger LM, Zhu K, Williams SA, Shrader M, Dinney CP, McConkey DJ. Cancer Res; 2005 Jun 01; 65(11):4902-8. PubMed ID: 15930312 [Abstract] [Full Text] [Related] Page: [Next] [New Search]